Download | March 6, 2013

Development Services: Low Solubility Compounds

Source: Patheon Inc.

A small biotech company contracted Patheon to design an oral solid formulation and supply material for Phase I clinical studies for a high dose insoluble drug. Minimal quantities of this drug were available and its stability was unknown.

For full access to this content, please Register or Sign In.

Access Content Development Services: Low Solubility Compounds